Karl W. Boehme

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI

Assistant Professor

UAMS

Also affiliated: University of Wisconsin–Madison (2003–2008); Vanderbilt University (2007–2014); Inflammatory Response Research (United States) (2022–2023); Cancer Research Center (2006); Winthrop Rockefeller Foundation (2021–2022); The University of Texas at San Antonio (2000); Technische Universität Berlin (2013); Vanderbilt University Medical Center (2009–2017)

Faculty Researcher

20 h-index 55 pubs 3,166 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website UAMS TRI Profile

OverviewAI-generated summary

Karl W. Boehme's research focuses on viral infections and host immune responses, with a significant portion of his work examining SARS-CoV-2 and reovirus.

He is the Principal Investigator on a $185,375 NIH/National Institute of Allergy and Infectious Diseases grant studying reovirus induction of host inflammatory responses. His publications include investigations into ACE2 autoantibodies following SARS-CoV-2 infection, pediatric SARS-CoV-2 seroprevalence in Arkansas, and temporal variations in seroprevalence by race and ethnicity. Boehme has also contributed to studies on the M2 gene's role in reovirus-induced myocarditis and the organization and future directions of the Serological Sciences Network (SeroNet) for COVID-19.

His scholarly output is marked by an h-index of 20 and over 3,151 citations across 55 publications. Boehme collaborates extensively with researchers at the University of Arkansas for Medical Sciences, including J. Craig Forrest, Joshua L. Kennedy, Laura P. James, and Shana M. Owens.

Metrics

h-index: 20
Publications: 55
Citations: 3,166

Selected Publications

Long-term effects of reovirus strain T3D on the myocardium (2026)

Microbiology Spectrum DOI OpenAlex
From defense to disease: the multifaceted role of lymphatics during infection (2025)

The Journal of Immunology DOI OpenAlex
The Mitochondrial Ubiquitin Ligase MARCHF5 Cooperates with MCL1 to Inhibit Apoptosis in KSHV-Transformed Primary Effusion Lymphoma Cell Lines (2024)

bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex
Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs (2024)

bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex
Timely T cell recruitment protects against viral myocarditis (2023)

Nature Cardiovascular Research DOI OpenAlex
A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University (2023)

Journal of American College Health 1 citation DOI OpenAlex
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization (2022)

mSphere 31 citations DOI OpenAlex
Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers (2022)

Journal of the American College of Emergency Physicians Open 1 citation DOI OpenAlex
State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020 (2022)

PLoS ONE 4 citations DOI OpenAlex
Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies (2022)

Open Forum Infectious Diseases 15 citations DOI OpenAlex
Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas (2022)

Open Forum Infectious Diseases 7 citations DOI OpenAlex
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization (2022)

medRxiv 2 citations DOI OpenAlex
Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic (2022)

Journal of the Pediatric Infectious Diseases Society 28 citations DOI OpenAlex
Abstract 11421: The M2 Gene is a Determinant of Reovirus-Induced Myocarditis (2021)

Circulation DOI OpenAlex
The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis (2021)

Journal of Virology 11 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $185,375 total

NIH Contact PI Jun 2023 - May 2026

Reovirus induction of host inflammatory responses

National Institute of Allergy and Infectious Diseases $185,375 R21

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

Center for Microbial Pathogenesis and Host Inflammatory Responses NIH
Characterization of the reovirus simga 1s protien. NIH
Mechanisms of Reovirus Bloodstream Dissemination NIH
Quang ACRI GR039080 Epidemiologic and Clinical Features of COVID-19 in Pediatric Patients and Healthcare Workers in the Pediatric Emergency Department: A Prospective, Observational Analysis (COVID) UAMS ACHRI Flow Through
Sub R01 Dr. Danthi - Continuation NIH/Nat. Inst. of Allergy & Infectious Diseases via Indiana University
Subaward to Indiana NIH/Nat. Inst. of Allergy & Infectious Diseases via Indiana University
DISCOVAR:Disparities in Immune Response to SARS-CoV-2 in ARkansas NIH